350 related articles for article (PubMed ID: 26426996)
1. c-MYC Copy-Number Gain Is an Independent Prognostic Factor in Patients with Colorectal Cancer.
Lee KS; Kwak Y; Nam KH; Kim DW; Kang SB; Choe G; Kim WH; Lee HS
PLoS One; 2015; 10(10):e0139727. PubMed ID: 26426996
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of the EGFR, HER2, c-MYC, and MET variations in colorectal cancer determined by three different measures: gene copy number gain, amplification status and the 2013 ASCO/CAP guideline criterion for HER2 testing of breast cancer.
Kwak Y; Yun S; Nam SK; Seo AN; Lee KS; Shin E; Oh HK; Kim DW; Kang SB; Kim WH; Lee HS
J Transl Med; 2017 Aug; 15(1):167. PubMed ID: 28764718
[TBL] [Abstract][Full Text] [Related]
3. Clinical and prognostic value of MET gene copy number gain and chromosome 7 polysomy in primary colorectal cancer patients.
Seo AN; Park KU; Choe G; Kim WH; Kim DW; Kang SB; Lee HS
Tumour Biol; 2015 Dec; 36(12):9813-21. PubMed ID: 26159851
[TBL] [Abstract][Full Text] [Related]
4. Favorable prognosis in colorectal cancer patients with co-expression of c-MYC and ß-catenin.
Lee KS; Kwak Y; Nam KH; Kim DW; Kang SB; Choe G; Kim WH; Lee HS
BMC Cancer; 2016 Sep; 16(1):730. PubMed ID: 27619912
[TBL] [Abstract][Full Text] [Related]
5. Digital polymerase chain reaction for detecting c-MYC copy number gain in tissue and cell-free plasma samples of colorectal cancer patients.
Lee KS; Nam SK; Seo SH; Park KU; Oh HK; Kim DW; Kang SB; Kim WH; Lee HS
Sci Rep; 2019 Feb; 9(1):1611. PubMed ID: 30733532
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast Growth Factor Receptor 1 Gene Copy Number and mRNA Expression in Primary Colorectal Cancer and Its Clinicopathologic Correlation.
Kwak Y; Nam SK; Seo AN; Kim DW; Kang SB; Kim WH; Lee HS
Pathobiology; 2015; 82(2):76-83. PubMed ID: 26088290
[TBL] [Abstract][Full Text] [Related]
7. The rs6983267 SNP is associated with MYC transcription efficiency, which promotes progression and worsens prognosis of colorectal cancer.
Takatsuno Y; Mimori K; Yamamoto K; Sato T; Niida A; Inoue H; Imoto S; Kawano S; Yamaguchi R; Toh H; Iinuma H; Ishimaru S; Ishii H; Suzuki S; Tokudome S; Watanabe M; Tanaka J; Kudo SE; Mochizuki H; Kusunoki M; Yamada K; Shimada Y; Moriya Y; Miyano S; Sugihara K; Mori M
Ann Surg Oncol; 2013 Apr; 20(4):1395-402. PubMed ID: 22976378
[TBL] [Abstract][Full Text] [Related]
8. The prognostic role of c-MYC amplification in schistosomiasis-associated colorectal cancer.
Pan W; Wang W; Huang J; Lu K; Huang S; Jiang D; Bu D; Liu J; Jing H; Yao J; Hou Y
Jpn J Clin Oncol; 2020 Apr; 50(4):446-455. PubMed ID: 32297641
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of Transcription Termination Factor 1 is Associated with a Poor Prognosis in Patients with Colorectal Cancer.
Ueda M; Iguchi T; Nambara S; Saito T; Komatsu H; Sakimura S; Hirata H; Uchi R; Takano Y; Shinden Y; Eguchi H; Masuda T; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1490-8. PubMed ID: 26036188
[TBL] [Abstract][Full Text] [Related]
10. Synergistic role of Cul1 and c-Myc: Prognostic and predictive biomarkers in colorectal cancer.
Wang W; Deng J; Wang Q; Yao Q; Chen W; Tan Y; Ge Z; Zhou J; Zhou Y
Oncol Rep; 2017 Jul; 38(1):245-252. PubMed ID: 28560438
[TBL] [Abstract][Full Text] [Related]
11. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
[TBL] [Abstract][Full Text] [Related]
12. Gene copy number gain of EGFR is a poor prognostic biomarker in gastric cancer: evaluation of 855 patients with bright-field dual in situ hybridization (DISH) method.
Higaki E; Kuwata T; Nagatsuma AK; Nishida Y; Kinoshita T; Aizawa M; Nitta H; Nagino M; Ochiai A
Gastric Cancer; 2016 Jan; 19(1):63-73. PubMed ID: 25487305
[TBL] [Abstract][Full Text] [Related]
13. Alterations of MET Gene Copy Number and Protein Expression in Primary Non-Small-Cell Lung Cancer and Corresponding Nodal Metastases.
Tran TN; Selinger CI; Kohonen-Corish MR; McCaughan B; Kennedy C; O'Toole SA; Cooper WA
Clin Lung Cancer; 2016 Jan; 17(1):30-8.e1. PubMed ID: 26395411
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneous EGFR gene copy number increase is common in colorectal cancer and defines response to anti-EGFR therapy.
Ålgars A; Avoranta T; Österlund P; Lintunen M; Sundström J; Jokilehto T; Ristimäki A; Ristamäki R; Carpén O
PLoS One; 2014; 9(6):e99590. PubMed ID: 24940619
[TBL] [Abstract][Full Text] [Related]
15. Genomic gain of the PRL-3 gene may represent poor prognosis of primary colorectal cancer, and associate with liver metastasis.
Nakayama N; Yamashita K; Tanaka T; Kawamata H; Ooki A; Sato T; Nakamura T; Watanabe M
Clin Exp Metastasis; 2016 Jan; 33(1):3-13. PubMed ID: 26563151
[TBL] [Abstract][Full Text] [Related]
16. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
Stanisavljević L; Myklebust MP; Leh S; Dahl O
Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of plastin-3 via copy number gain induces the epithelial-mesenchymal transition in circulating colorectal cancer cells.
Sugimachi K; Yokobori T; Iinuma H; Ueda M; Ueo H; Shinden Y; Eguchi H; Sudo T; Suzuki A; Maehara Y; Mori M; Mimori K
Ann Surg Oncol; 2014 Oct; 21(11):3680-90. PubMed ID: 24217791
[TBL] [Abstract][Full Text] [Related]
18. Nuclear Notch3 expression is associated with tumor recurrence in patients with stage II and III colorectal cancer.
Ozawa T; Kazama S; Akiyoshi T; Murono K; Yoneyama S; Tanaka T; Tanaka J; Kiyomatsu T; Kawai K; Nozawa H; Kanazawa T; Yamaguchi H; Ishihara S; Sunami E; Kitayama J; Morikawa T; Fukayama M; Watanabe T
Ann Surg Oncol; 2014 Aug; 21(8):2650-8. PubMed ID: 24728738
[TBL] [Abstract][Full Text] [Related]
19. MYC and human telomerase gene (TERC) copy number gain in early-stage non-small cell lung cancer.
Flacco A; Ludovini V; Bianconi F; Ragusa M; Bellezza G; Tofanetti FR; Pistola L; Siggillino A; Vannucci J; Cagini L; Sidoni A; Puma F; Varella-Garcia M; Crinò L
Am J Clin Oncol; 2015 Apr; 38(2):152-8. PubMed ID: 25806711
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation of over-expressed IL-32 in colorectal cancer induces metastasis.
Yang Y; Wang Z; Zhou Y; Wang X; Xiang J; Chen Z
World J Surg Oncol; 2015 Apr; 13():146. PubMed ID: 25889282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
